about
The therapeutic potential of metal-based antimalarial agents: implications for the mechanism of actionPyronaridine for treating uncomplicated malariaThe safety of amodiaquine use in pregnant womenChloroquine-resistant isoforms of the Plasmodium falciparum chloroquine resistance transporter acidify lysosomal pH in HEK293 cells more than chloroquine-sensitive isoforms.Identification of inhibitors of Plasmodium falciparum phosphoethanolamine methyltransferase using an enzyme-coupled transmethylation assay.Pharmacokinetics of artesunate alone and in combination with sulfadoxine/pyrimethamine in healthy Sudanese volunteersIn vitro and in vivo interactions between miltefosine and other antileishmanial drugsAndrographolide: A Novel Antimalarial Diterpene Lactone Compound from Andrographis paniculata and Its Interaction with Curcumin and Artesunate.Diversity-oriented synthesis and activity evaluation of substituted bicyclic lactams as anti-malarial against Plasmodium falciparumMalaria in the post-genomics era: light at the end of the tunnel or just another train?Analyzing a Potential Drug Target N-Myristoyltransferase of Plasmodium falciparum Through In Silico ApproachesDrug resistance hampers our capacity to roll back malaria.Drug-resistant malariaEnhanced antimalarial effects of chloroquine by aqueous Vernonia amygdalina leaf extract in mice infected with chloroquine resistant and sensitive Plasmodium berghei strainsDrug-resistant malaria - an insight.MMV in partnership: the Eurartesim® experience.Evaluation of artemisinins for the treatment of acute myeloid leukemia.Malaria and oral health.Inhibition of P-glycoprotein-mediated paclitaxel resistance by reversibly linked quinine homodimersCrystal structure and solution characterization of the thioredoxin-2 from Plasmodium falciparum, a constituent of an essential parasitic protein export complex.In vitro and in vivo characterization of the antimalarial lead compound SSJ-183 in Plasmodium models.Malaria and iron: history and review.Toxicity of the antimalarial artemisinin and its dervatives.Advances in quantitative structure-activity relationship models of antimalarials.New uses for old drugs: the tale of artemisinin derivatives in the elimination of schistosomiasis japonica in China.Structure and reactivity of Trypanosoma brucei pteridine reductase: inhibition by the archetypal antifolate methotrexate.Descriptive study on the efficacy of artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Sudan.Evidence basis for antimalarial policy change in Sierra Leone: five in vivo efficacy studies of chloroquine, sulphadoxine-pyrimethamine and amodiaquine.Redetermination of {5-[(7-chloro-quinolinium-4-yl)amino]-2-hy-droxy-benz-yl}diethyl-ammonium dichloride dihydrate.Making a difference: 30 years of TDR.Designing organometallic compounds for catalysis and therapy.Investigation into in vitro anti-leishmanial combinations of calcium channel blockers and current anti-leishmanial drugs.A highly effective one-pot synthesis of quinolines from o-nitroarylcarbaldehydes.Methylene blue for treating malaria
P2860
Q20906133-46523C77-C32A-4A1F-9894-B534B99BD664Q24243752-B3232445-B539-4A67-8F9E-DB8F0097775EQ28255205-198C36AE-0A43-414C-A7D0-8EC6C408A94BQ30357176-54A69143-FFFF-4950-A15C-2EC925C6F870Q33525180-9FBFEA3A-FFC3-4861-8590-A42DA891435BQ33719587-BED21A22-BD9D-437E-AD65-9DCCC2654A9EQ34301638-79161957-3FDB-43BB-BF6A-274847A6C7AEQ35098931-4256B705-84B9-4156-BE1D-2ABA7B438D93Q35457856-77ECC36F-D190-4D60-8B2D-48506F1B65A6Q35522550-E2EFC22E-E438-4361-A65D-1C1F8BA81BABQ35890499-1ECBFDC4-03CE-4FF9-974A-80B19ED43754Q36201223-6EE8F7A0-82F1-477E-AD15-13C9794E1D17Q36248426-821C017D-2F15-4B64-87E7-DF03D1D896CAQ36691316-59C1864F-38CA-4815-A349-643ACE95073CQ36933785-67B07A43-260E-4748-A69E-0451CAC31557Q36952896-9066D10B-E39A-457E-B991-2C757C0E1C25Q37033027-08D9010E-8019-4D0A-AEA2-47E72A18C351Q37056675-96FF2186-CF85-441E-AFD1-7E5969A16E3BQ37199454-092C1B87-ABE4-4686-BED1-C96B99C84A76Q37255674-34511A32-4674-4DD6-BF51-1D8B7E95DD7EQ37320938-F87C045E-1103-4794-8705-587BCEAF01DBQ37599856-D58D82BB-83B0-4F93-BBBC-08300F2D2BE2Q37693152-B8686C8D-5EC9-4F96-91D7-F5E949013CDCQ38029140-6EA2F2F1-72DD-4EAB-8E1D-3BDE8216A5B4Q38253124-B126FEFD-7686-48C8-B8B9-6C6B17F7596EQ38784214-A7783C9A-0375-4066-920F-0E1221715994Q40365263-717F3A73-9E17-4D3A-82E4-786E1012FD6DQ40516074-3884D97E-44A0-4BCE-A0A9-F965E996F053Q41390143-82482F67-0036-401F-AF81-5A657C1CCFEBQ46642960-D0BBF4AB-7473-48B1-B8E9-6E8514D787A1Q48007506-57AA702B-9D38-4C37-8112-623827700F6EQ51761966-A44C0D6D-D493-4A69-BDDC-99B21931B62BQ53582755-9A9F1B40-1A06-49A0-B8AC-A8B6B59574C0Q56785617-40953DD3-140E-4543-B7DF-3EDF9D690864
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Antimalarial compounds: from bench to bedside.
@ast
Antimalarial compounds: from bench to bedside.
@en
type
label
Antimalarial compounds: from bench to bedside.
@ast
Antimalarial compounds: from bench to bedside.
@en
prefLabel
Antimalarial compounds: from bench to bedside.
@ast
Antimalarial compounds: from bench to bedside.
@en
P356
P1476
Antimalarial compounds: from bench to bedside.
@en
P2093
Piero L Olliaro
Walter R J Taylor
P304
P356
10.1242/JEB.00653
P577
2003-11-01T00:00:00Z